Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Single-Dose Study of Prasinezumab (RO7046015) in Healthy Japanese Men
jRCT2080223775Phase 1
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jan 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, single-arm trial of prasinezumab in Parkinson's disease (PD), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
prasinezumab
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080223775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223775.